LncRNA GNAS-AS1 Facilitates ER+ Breast Cancer Cells Progression by Promoting M2 Macrophage Polarization Via Regulating MiR-433-3p/GATA3 Axis
Overview
Affiliations
Objective: ER+ breast cancer is the most common type of breast cancer, which seriously affects the physical and mental health of women. Recently, lncRNAs mediated tumor-associated macrophages (TAM) were identified to involve in tumorigenesis. Therefore, the present study aimed at demonstrating the regulatory network of GNAS-AS1 in TAM-mediated ER+ breast cancer progress.
Methods: The expression levels of genes were evaluated using qRT-PCR. The proportions of polarized macrophages (M1, M2) were assessed by flow cytometry. Cell proliferation, migration and invasion were evaluated by CCK-8, wound healing and transwell assay, respectively. Double-luciferase reporter system was used to detect the interaction between molecules. Western blot was applied to test protein levels.
Results: The expression of GNAS-AS1 was obviously increased in ER+ breast cancer tissues and cell lines, as well as M2 macrophages. GNAS-AS1 facilitated the capabilities of proliferation, migration and invasion of ER+ breast cancer cells by accelerating M2 macrophage polarization via directly sponging miR-433-3p. GATA3, as a target of miR-433-3p, could positively regulate by GNAS-AS1. Furthermore, either miR-433-3p overexpression or GATA3 knockdown impaired the effects of GNAS-AS1 on M2 macrophage polarization and ER+ breast cancer cells progression.
Conclusion: GNAS-AS1/miR-433-3p/GATA3 axis promoted proliferation, metastasis of ER+ breast cancer cells by accelerating M2 macrophage polarization. The mechanism may provide a new strategy and target for ER+ breast cancer treatment.
Macrophage subtypes inhibit breast cancer proliferation in culture.
Varady S, Greiner D, Roh-Johnson M Mol Biol Cell. 2024; 36(1):br2.
PMID: 39602294 PMC: 11742110. DOI: 10.1091/mbc.E24-06-0241.
Bioinformatic and experimental analyses of GATA3 and its regulatory miRNAs in breast Cancer.
Roohy F, Moghanibashi M, Tahmasebi S Discov Oncol. 2024; 15(1):588.
PMID: 39448444 PMC: 11502614. DOI: 10.1007/s12672-024-01479-y.
Non-coding RNAs as therapeutic targets in cancer and its clinical application.
Leng X, Zhang M, Xu Y, Wang J, Ding N, Yu Y J Pharm Anal. 2024; 14(7):100947.
PMID: 39149142 PMC: 11325817. DOI: 10.1016/j.jpha.2024.02.001.
Gao H, Ding C, Chang M, Lu Z, Li D, Bi D IET Syst Biol. 2024; 18(4):143-154.
PMID: 39051498 PMC: 11336057. DOI: 10.1049/syb2.12096.
Macrophage subtypes inhibit breast cancer proliferation in culture.
Varady S, Greiner D, Roh-Johnson M bioRxiv. 2024; .
PMID: 38853881 PMC: 11160732. DOI: 10.1101/2024.06.01.596963.